1. A Linear Discriminant Analysis Model Based on the Changes of 7 Proteins in Plasma Predicts Response to Anlotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients
   Fei Xu et al, 2022, Frontiers in Oncology CrossRef
2. PD-L1 Expression Is Associated With VEGFA and LADC Patients' Survival
   Shaochuan Liu et al, 2019, Frontiers in Oncology CrossRef
3. Evaluation of Patients with Lung Cancer
   Gokcen Ömeroğlu Şimşek et al, 2023, Airway diseases CrossRef
4. Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A clinicopathological study
   Shi-Lin Lv et al, 2024, World Journal of Gastrointestinal Oncology CrossRef
5. BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer
   Shuyi Cen et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
6. Hypoxia in Lung Cancer Management: A Translational Approach
   Julien Ancel et al, 2021, Cancers CrossRef
7. Cancer Therapeutic siRNA Delivery and Imaging by Nitrogen- and Neodymium-Doped Graphene Quantum Dots
   Alina R. Valimukhametova et al, 2023, ACS Biomaterials Science & Engineering CrossRef